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Abstract
Background: Quality improvement in health care requires identification of areas in need of improvement by comparing
processes and patient outcomes within and between health care providers. It is critical to adjust for different case-mix
and outcome risks of patient populations but it is currently unclear which approach has higher validity and how
limitations need to be dealt with. Our aim was to compare 3 approaches towards risk adjustment for 7 different
major quality indicators in neonatal intensive care (21 models).
Methods: We compared an indirect standardization, logistic regression and multilevel approach. Parameters for
risk adjustment were chosen according to literature and the condition that they may not depend on processes
performed by treating clinics. Predictive validity was tested using the mean Brier Score and by comparing area
under curve (AUC) using high quality population based data separated into training and validation sets. Changes
in attributional validity were analysed by comparing the effect of the models on the observed-to-expected ratios
of the clinics in standardized mortality/morbidity ratio charts.
Results: Risk adjustment based on indirect standardization revealed inferior c-statistics but superior Brier scores for 3 of
7 outcomes. Logistic regression and multilevel modelling were equivalent to one another. C-statistics revealed
that predictive validity was high for 8 and acceptable for 11 of the 21 models. Yet, the effect of all forms of risk
adjustment on any clinic’s comparison with the standard was small, even though there was clear risk heterogeneity
between clinics.
Conclusions: All three approaches to risk adjustment revealed comparable results. The limited effect of risk adjustment
on clinic comparisons indicates a small case-mix influence on observed outcomes, but also a limited ability to isolate
quality improvement potential based on risk-adjustment models. Rather than relying on methodological approaches,
we instead recommend that clinics build small collaboratives and compare their indicators both in risk-adjusted and
unadjusted form together. This allows qualitatively investigating and discussing the residual risk-differences within
networks. The predictive validity should be quantified and reported and stratification into risk groups should be
more widely used to correct for confounding.
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Background
Risk adjustment is ubiquitously used to compare health
care providers for the identification of quality improve-
ment potential. Its effectivity is usually accepted as
given. Literature reports an abundance of variations in
vital patient outcome measures between clinics, regions
and even networks, as shown, for instance, in neonat-
ology [1–3]. Could these clinics, regions or networks all
achieve the same potentially best standard, the resulting
effect would dwarf many successful introductions of new
drugs or methods. Over the last 20 years, several neo-
natal networks have shown beneficial developments for
patients that were associated with quality improvement
efforts [4–7].
A number of publications have addressed the need for
risk adjustment in quality improvement [8–10]. Several
of the introduced models rely on processes or diagnos-
tics performed by the site under observation, thereby
inadvertently adjusting for factors that may well be in
need of improvement [11].
The use of risk-adjustment thereby assumes that the
discrepancy between predicted and observed outcome is
at least partially attributable to the quality of care pro-
vided. If the observed outcome exceeds the predicted
outcome, then this discrepancy is assumed to be due to
poor care. To which degree this assumption is valid is an
important but often neglected aspect of the validation of
risk-adjustment methods [12, 13]. Literature therefore
recommends observing predictive and attributional valid-
ity to assess the validity of the risk adjustment approaches.
The predictive validity is the extent to which the method
accurately predicts the probability of outcome whereas
the attributional validity allows attributing differences in
outcome to the quality of care [12].
As a national neonatal network, our aim was to setup a
reliable, clinic-independent, achievable quality improve-
ment concept for several vital outcome measures and test
its validity. For this, we compared 3 approaches for adjust-
ing our 7 most important outcome measures for very
preterm born children and analysed their effect on the
differences that the clinics show for these outcomes.
Methods
Study population
The study includes data on all children born alive
between 22 0/7 and 31 6/7 weeks gestational age
during the years 2006 to 2014 that were prospectively
collected in our national, population based registry
(SwissNeoNet). Data are collected electronically from
birth until death or first discharge home by all nine
Level III and three of six Level IIB neonatal units
using immediate plausibility and completeness checks
and subsequent repeated challenge until corrected. All
items are defined in a publicly available manual [14].
They cover typical aspects of perinatal care, demo-
graphics, common diagnoses and treatments, growth
and hospitalization duration. In this study we include
all infants born between 2006 and 2014. Population
coverage was assessed by comparison with the birth
registry of the Swiss Federal Statistical Office yielding
94% completeness when including births of non-
resident mothers living outside Switzerland.
Outcome definitions
We selected outcomes that were strictly defined and
whose incidence was alterable by variations in process or
structure [9, 15]. Overall mortality was calculated for all
infants born alive. The following proportions of new-
borns with the respective outcome (i.e. cumulative
incidence proportion over a 9-year time span) were based
on infants admitted to a NICU: in-hospital mortality; late
onset sepsis with clear clinical evidence of infection as well
as at least one microbiologically relevant positive blood
culture occurring after day 3 of life (with day of birth as
day 1); necrotizing enterocolitis (NEC) was defined as
clinical signs (abdominal distension, bilious aspirates and/
or bloody stools) confirmed by radiographically visible
intramural gas or at laparotomy (Bell stages 2 and 3); [16]
severe intraventricular haemorrhage (sIVH) was based
on the most severe ultrasound result during hospital
stay using stages 3 to 4 of the classifications defined by
Papile et al. [17]. The remaining outcome incidence
proportions were based on infants discharged home
alive: severe retinopathy of prematurity (sROP) using
the international classification published by the com-
mittee for the classification of ROP grades 3–4; [18]
and bronchopulmonary dysplasia (BPD) defined as an
oxygen requirement at 36 weeks gestational age accord-
ing to the NICHD consensus conference paper [19].
Risk adjustment parameter definitions (risk adjustors)
We selected risk adjustors that were first and foremost
predictive, i.e. known to vary with changes in severity in
outcomes. Beyond this, they were easily available to
restrict bias due to missing data, measurable, frequent, re-
liable, and accurately recorded with limited interpretation
margins to minimize definition bias [9]. Another selection
criterion was that they were consistent with literature, i.e.
that their validity has already been documented for the
listed outcomes [10, 11, 20]. Our risk adjusters also hold
the ability to be updated periodically, based on an ongoing
research commitment and investment [8].
The following risk adjusters were included in the
model: Gestational age (GA), GA squared (GA2), birth-
weight z-score (BW z-score), male sex, multiples, Apgar
at 1 min, major malformation, outborn and parent socio
economic status (SES). GA was calculated based on
ultrasound examinations during the first trimester of
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pregnancy and defined as postmenstrual age in weeks
and days. Major congenital malformation was defined
as any type of malformation severely impacting progno-
sis (e.g. complex congenital heart disease, malformation
syndromes). SES was estimated by a validated 12-point
socioeconomic score based on maternal education and
current paternal occupation whereas the value 2 designates
the combination of highest education and occupation
versus the value 12 which represents no education and no
occupation [21]. Outborn designates an infant transferred
to any one of the 12 participating units after birth.
Statistical methods
Based on the risk-adjustment methodology published in
literature, three approaches were compared: indirect
standardization based on the units’ individual distribu-
tion of children into gestational age weeks, the most
commonly used multivariable logistic regression to
account for multiple confounding variables, and multi-
variable multilevel modelling [5, 22, 23]. The latter was
added in case clustering of data into neonatal units
should be of importance. A previous publication
revealed that the survival of Swiss infants with very low
gestational age without severe neonatal morbidity was
strongly influenced by the medical centre that treated
them [24]. Data of infants born from 2006 to 2012 were
used for model building (training set) whereas data from
2013 to 2014 were used for goodness-of-fit analysis
(validation set). This split was performed to avoid
overfitting, to be able to use the best acquired model on
our own data and to accurately describe what effect each
model has on the observed-to-expected ratios of the clinics.
In order to avoid collinearity between GA and
birthweight, birthweight entered the model as z-scores
relative to GA based on the growth curves published by
Voigt et al. [25]. To better model the non-linear depend-
ency of most neonatal outcomes on gestational age, its
quadratic value (GA2) was included into the latter 2
models. As several of the examined outcomes are known
to have improved over the years, [26] year was added as
a covariate as a continuous variable assigning the value 0
to the last year (2012) and subtracting 1 for each
previous year (value range [−6, 0]); this covariate adjusts
the remaining predictors for a linear effect of time. It
was omitted in validation.
As one of the predictors, i.e. SES, yielded 20% missing
values in the entire dataset, equally distributed over the
years but with higher concentration on datasets of
infants that died in the delivery room, we first calcu-
lated the models using fivefold imputation with chained
equations [27]. The results were compared to those
resulting from models without imputation and without
SES as predictor. Models with imputation and SES were
used only if SES yielded a significant adjusted odds
ratio (i.e. 95% confidence interval outside 1). All other
predictors yielded less than 2% missing data and were
therefore not treated separately. No other model selec-
tion process was undertaken.
In the multilevel models, centre was included as a
random intercept to adjust for centre differences while
providing parameter estimates to permit centre-free pre-
dictions [20]. As the compared units were all of the same
standard (swiss perinatal units are legally required to fulfil
the same structural qualifications on staffing and equip-
ment), we did not add any cluster level covariates. All stat-
istical analyses were performed using R [28]. P-values
below 0.05 were considered significant.
Validity assessments
To compare predictive validity of the different adjust-
ment approaches, we compared the mean Brier score
and the area under receiver operating characteristics
curve (AUC). The Brier score measures the accuracy of
probabilistic predictions as the mean squared difference
between the predicted probability assigned to the
possible outcome and the actual outcome. The closer
the score is to 0, the better the sharpness and calibration
of the prediction. A poor Brier score of 0.25 is reached
by assigning each patient with a constant probability of
0.5 for the outcome [29]. AUC values between 0.7–0.8
were considered to represent moderate predictive
validity whereas and >0.8 to represent high predictive
validity. As no goodness-of-fit can be calculated for
indirect standardization, comparison was approximated
using a logistic regression model based on gestational
weeks alone. The difference in prediction between both
was less than 0.5% (Additional file 1: Table S1).
As we were not able to measure attributional validity,
we instead measured changes to attributional validity by
assessing what the effect of a specific risk adjustment
model was on the differences seen in the risk-adjusted
outcome measures. Standardized mortality / morbidity
ratios were calculated as observed over expected ratios for
each clinic. Expected outcome per clinic was calculated as
sum of standardized outcome ratio per gestational age
week in the case of indirect standardization and per each
clinic’s sum of individual patient probabilities (0 < p < 1)
to acquire a specific outcome in the case of logistic regres-
sion or multilevel modelling, respectively. Individual
patient probability was calculated as P(Y = 1| Xi=xi) =
exp(β0+β1X1+… + βnXn)/1 + exp(β0+β1X1+… + βnXn).
Results
Table 1 lists the 6 outcome variables and the propor-
tion of new-borns presenting the respective outcome
(i.e. cumulative incidence proportion) for which risk
adjustment was performed. It also reveals the avail-
able data for prediction modelling and sensitivity
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analysis and the number of valid responses per
outcome. Proportions are relative to the number of
valid responses. There were sufficient data available
for model building and testing. Other than severe
ROP, for which 11% of data were estimated using
data imputation, the outcomes had a maximum of ten
missing valid responses.
Table 2 compares the predictive validity of the three
approaches for risk adjustment: indirect standardization
based on GA stratification, logistic regression and
multilevel modelling. Model parameters were calculated
using the training set while prediction was tested using
the validation set. For mortality, in hospital mortality
and BPD, the indirect standardization had an inferior
AUC but a superior Brier score. All other outcomes
revealed close to identical Brier scores and a very simi-
lar AUC, whereas the values for logistic regression and
multilevel modelling overall were almost identical. The
variances of the random effect intercepts were all below
1.5 (not shown).
The 3 risk adjustment approaches over 7 outcomes
yielded 21 risk adjustment models. Nineteen of these
models reached a Brier Score below 0.1. Equally 19
reached at least an acceptable predictive validity
(AUC > 0.7) of which 11 even reached a high predictive
validity (AUC > 0.8) (Table 2).
Next we looked at the effect each risk adjustment
approach had on the distribution of the individual clinic’s
outcomes in the standardized mortality / morbidity ratio
(SMR) charts in order to ascertain if the differences in
case-mix were effectively adjusted for and the remaining
differences can be attributed to differences in care. SMR
charts are ubiquitously used to analyse a clinic’s perform-
ance by comparing the risk adjusted ratio of observed to
expected mortality / morbidity cases to a standard popula-
tion as shown in Fig. 1. For this we first determined for
each model the number of clinics in the validation set
whose observed to expected ratio were above 1, i.e. worse
than expected, the value that usually interests the
clinicians most (Table 3a). Mortality, in-hospital mortality
Table 1 Outcomes observed, collective used, study population size (N), valid responses per outcome (valid N) and cumulative incidence
proportions (%) for prediction modelling and sensitivity analysis
Variable Collective 2006–2012 2013–2014
Training set Validation set
Na valid % N valid %
Mortality All Live-born 5212 5212 14.6 1572 1572 14.0
In hospital mortality Admitted to ward 4876 4874 8.8 1465 1465 7.7
Late onset sepsis 4874 9.5 1465 8.1
NECb 4874 2.4 1465 2.4
sIVHc 4865 6.5 1459 5.7
BPDd Discharged home alive 4449 4439 9.3 1352 1349 11.2
sROPe 3990 1.9 1200 1.6
aN Sample size for analysis
bNEC Necrotizing enterocolitis
csIVH intra−/periventricular haemorrhage grade 3–4
dBPD bronchopulmonary dysplasia
esROP retinopathy of prematurity grade 3 and above
Table 2 Predictive validity for indirect standardization, logistic regression and multilevel random intercept approach respectively using
the mean Brier score and AUC for assessing the predictive abilities of the respective model using the validation set
Indirect Standardization Logistic regression Multilevel
Variable Brier Score AUC Brier Score AUC Brier Score AUC
Mortality 0.070 0.896 0.113 0.935 0.109 0.936
In hosp. mortality 0.060 0.831 0.095 0.892 0.093 0.893
Late onset sepsis 0.068 0.788 0.067 0.804 0.067 0.803
NECa 0.023 0.716 0.024 0.694 0.024 0.694
sIVHb 0.050 0.765 0.049 0.786 0.049 0.786
BPDc 0.084 0.807 0.195 0.843 0.195 0.843
sROPd 0.015 0.765 0.016 0.773 0.016 0.773
aNEC Necrotizing enterocolitis. Values based on imputed data
bsIVH intra−/periventricular haemorrhage grade 3–4
cBPD bronchopulmonary dysplasia
dsROP retinopathy of prematurity grade 3 and above. Values based on imputed data
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Fig. 1 Standardized morbidity ratio chart displaying late onset sepsis prediction for 9 Swiss NICUs with 95% confidence intervals (screenshot from
SwissNeoNet member platform). Blue: crude observed over expected data, green: risk adjusted relation of observed to expected deaths in hospital
(including delivery room). Expected deaths were calculated as sum of each child’s probability to die depending upon the predictor values listed in Table 4
Table 3 Effect of risk-adjustment approach on standardized mortality/morbidity ratio chart. a) Number of clinics with observed-expected
ratio > 1. b) Cumulative absolute distances of observed-expected ratio of all clinics to the standard value 1
Raw values Indirect standardization Logistic regression Multilevel
Outcome a) SMR values above 1
Mortality 3 3 3 3
In hosp. Mortality 3 3 3 3
Late onset sepsis 4 2 2 2
NECa 3 4 3 3
sIVHb 5 5 6 6
BPDc 4 4 4 4
sROPd 2 2 1 2
b) Cumulative absolute distances to 1
Mortality 2.8 2.7 3.0 3.0
In hosp. Mortality 3.0 3.2 3.1 3.0
Late onset sepsis 2.7 3.0 3.0 3.1
NEC 3.4 3.4 3.6 3.6
sIVH 2.2 2.3 2.4 2.4
BPD 4.1 3.2 3.8 3.8
sROP 5.7 5.4 5.4 5.5
Total 23.9 23.2 24.3 24.4
aNEC Necrotizing enterocolitis
bsIVH intra−/periventricular haemorrhage grade 3–4
cBPD bronchopulmonary dysplasia
dsROP retinopathy of prematurity grade 3 and above
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and BPD listed the same amount of SMR values above 1.
The values for the other outcomes remained largely
untouched. To determine if these values above 1 represent
the same clinics, we analysed all of the 252 possible SMR
changes generated out of the total of 7 (outcomes) × 9
(clinics) × 4 (approaches) (not shown). Of 252 possible
changes of orientation between all approaches, a total of
14 changes were observed, 7 of which were between raw
values and all other risk adjustment models, and 7
between indirect standardization and unadjusted as well
as adjusted models. These changes of orientation concern
clinics with observed to expected ratios close to one.
There was no other fluctuation of clinics from above to
below one due to risk adjustment. Our second analysis
concerned the cumulative absolute distance of the
observed to expected ratio from 1 for each approach in
order to determine if the approaches lead to larger or
smaller overall differences between clinics (Table 3b).
Absolute here means that the distances of all clinics above
and below one are summarized. The higher the value, the
more the clinics seem to differ from each other. Again,
the differences between the approaches per outcome are
marginal but somewhat higher when using a logistic
regression or multilevel approach. In order to exclude that
the lack of effect of risk adjustment is based on a lack of
difference between the clinics’ risk potential, we calculated
the expected mortality for the clinic with the lowest risk
in the validation set as 11.2% versus 15.9% for the clinic
with the highest risk according to the logistic regression
model (AUC 0.935). Thus, the risk heterogeneity between
the two clinics lies at 40%.
Table 4 summarizes the adjusted odds ratios of the
risk adjustors per approach (indirect standardization,
logistic regression and multilevel). Our indirect
standardization approach relies on gestational age
stratification alone which explains the difference be-
tween the odds ratios per outcome in comparison with
the other approaches. The risk adjustor’s odds ratios for
the logistic regression and the multilevel approach are
however largely congruent with only marginal differ-
ences, explaining the close comparability in the
analyses above. The cumulatively strongest effect, i.e.
the largest difference in relation to 1, is attributable to
gestational age. A relatively high impact on some of the
models is observable in major malformation. SES score
only had an effect for the outcome NEC [OR 1.13, 95%
CI 1.04–1.22] (note that the highest SES score (12)
stands for lowest socio economic status whereas the
lowest score (2) stands for the highest SES collected).
Discussion
In our study we analyse prospectively collected popula-
tion based data with high population coverage. The aim
was to develop and compare risk adjustment models for
quality improvement purposes within a network of 12
Swiss neonatal units. The selected outcomes for risk
adjustment represent some of the most important out-
come measures in the field of neonatology [30]. We se-
lected the two well-known and most often implemented
approaches for risk adjustment, indirect standardization
and logistic regression modelling and added a multilevel
approach due to the nested data structure in which
patients were associated with a particular clinic and its
ability to provide clinic-independent predictions. Both
prediction and outcome parameters fulfil multiple
requirements for risk adjustment. Over half of the 21
risk adjustment models (three risk adjustment approaches
for 7 outcomes each) yielded high predictive validity in
the validation set with a majority of the remaining models
being at least moderately predictive. In summary, the
three risk adjustment approaches are similar to each other
and lead to results that differ marginally when compared
with the unadjusted raw outcome comparisons.
The simplest approach, indirect standardization based
on GA, performed surprisingly well in comparison and
may be more useful for quality assessments than previ-
ously thought. This may be due to the high impact of
gestational age on outcome in very preterm infants and
may not be generalizable into other areas of medicine.
Nevertheless, reduction to one reliably available risk
parameter may have removed bias that lead to an infer-
ior accordance between predicted and true values in the
multivariable approach. New medical registries without
available previous data could profit from the observation
that a non-model based approach achieves comparable if
not better calibrated results to model based approaches.
The lack of differences between the logistic regression
and the multilevel approach and the small variances of
the random effect intercepts of the multilevel model
revealed that the effect of a nested data structure is
lower than expected for a neonatal setting [20].
In summary, the three approaches reveal very little
difference in predictive or attributional validity between
each other. Nevertheless, their ability to isolate quality im-
provement potentials of the units is limited. This was
unexpected because the predictive validities for the care-
fully selected models were high. Also, large differences
between Swiss clinics are documented in literature [24]
and by a heterogeneity in risk potential between the clinics
of up to 40%. Nevertheless, neither of the risk adjustment
models had a discernible effect on the observed to
expected ratios of the seven outcome parameters, neither
in their absolute orientation (above or below 1) or in their
distance to 1 (1 meaning that observed and expected are
equal). The differences between units that remains after
risk adjustment can therefore not be attributed to the
quality of care alone. In neonatology, for instance, there
are factors that contribute to the differences between
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clinics other than risk or quality of care. Even though there
are national guidelines toward treatment at the limit of
viability, [31] the Swiss clinics are known to adopt differ-
ent approaches towards the care of infants born below
25 weeks GA. Clinics with a more active approach
towards resuscitation in the delivery room will have a
lower mortality but a higher risk for morbidities as the
decision about whether to provide active treatment at
birth is a critical predictor of subsequent outcomes in
itself [32]. This can partially be adjusted for by stratified
analysis of outcome of infants receiving active treatment,
in our case “admitted to ward”. But a more active
approach which yields a higher risk may still lead to higher
survival without impairment as recently shown by Rysavy
et al. [33].
In 1997, Iezzoni reported on a series of studies
comparing the effect of different severity of illness
scores on risk adjustment and concluded that al-
though hospitals vary in their unadjusted death rates,
severity failed to explain these differences fully leaving
the central question unresolved: “does severity adjust-
ment isolate that residual quantity, namely quality of
care differences across hospitals?” [34] Also using a
severity score, Thomas et al. found that hospital mor-
tality performance was significantly related to quality
of care for only 3 of 10 conditions evaluated [35].
The primary finding of a recent Monte Carlo simula-
tion on the relationship between the predictive valid-
ity of the risk-adjustment model and the accuracy of
hospital quality reports found that the relationship
Table 4 Odds ratios (OR) with standard errors (SE) of the risk adjustment parameters for each outcome and each risk adjustment
(RA) approach
Outcome RA approach GAa GA2 BWb
z-score
Male sex Multiples Apgar1 Major
malformation
outborn SESc
OR SE OR SE OR SE OR SE OR SE OR SE OR SE OR SE OR SE
Mortality Indirect
standardization
0.52 0.02 - - - - - - - - - - - - - - - -
Logistic regression 0.20 0.12 1.10 0.01 0.88 0.06 1.07 0.11 1.03 0.12 0.74 0.02 7.88 0.19 0.76 0.27 - -
Multilevel 0.19 0.12 1.10 0.01 0.84 0.06 1.09 0.11 1.03 0.12 0.74 0.02 8.62 0.20 0.74 0.28 - -
In hosp.
Mortality
Indirect
standardization
0.57 0.03 - - - - - - - - - - - - - - - -
Logistic regression 0.31 0.15 1.06 0.01 0.81 0.06 1.13 0.11 1.08 0.13 0.79 0.02 4.65 0.24 0.94 0.27 - -
Multilevel 0.28 0.15 1.07 0.01 0.79 0.06 1.16 0.12 1.06 0.13 0.80 0.02 5.34 0.24 0.89 0.28 - -
Late onset
sepsis
Indirect
standardization
0.68 0.02 - - - - - - - - - - - - - - - -
Logistic regression 1.11 0.14 0.96 0.01 0.71 0.06 0.95 0.10 0.83 0.12 1.03 0.02 1.32 0.28 1.08 0.24 - -
Multilevel 1.02 0.15 0.96 0.01 0.68 0.06 0.96 0.10 0.79 0.12 1.03 0.02 1.48 0.29 0.98 0.24 - -
NECd Indirect
standardization
0.81 1.04 - - - - - - - - - - - - - - - -
Logistic regression 1.12 1.30 0.98 1.02 0.78 1.11 1.12 1.21 1.13 1.23 0.91 1.04 1.00 1.69 1.30 1.46 1.11 1.04
Multilevel 1.09 1.30 0.98 1.02 0.78 1.11 1.13 1.21 1.11 1.23 0.91 1.04 1.01 1.69 1.32 1.46 1.11 1.04
sIVHe Indirect standardization 0.65 0.03 - - - - - - - - - - - - - - - -
Logistic regression 0.64 0.16 1.01 0.01 1.30 0.07 1.28 0.12 1.18 0.13 0.85 0.03 0.69 0.41 1.37 0.25 - -
Multilevel 0.63 0.16 1.01 0.01 1.31 0.07 1.27 0.12 1.19 0.13 0.85 0.03 0.69 0.41 1.33 0.25 - -
BPDf Indirect standardization 0.62 0.03 - - - - - - - - - - - - - - - -
Logistic regression 0.79 0.17 0.98 0.01 0.53 0.07 1.60 0.12 1.03 0.13 0.94 0.02 3.91 0.27 1.18 0.27 - -
Multilevel 0.73 0.17 0.99 0.01 0.52 0.07 1.60 0.12 1.01 0.13 0.94 0.02 4.40 0.27 1.11 0.27 - -
sROPg Indirect standardization 0.47 1.07 - - - - - - - - - - - - - - - -
Logistic regression 0.45 1.42 1.01 1.03 0.75 1.16 1.23 1.28 1.26 1.31 0.93 1.05 1.06 2.17 1.51 1.73 0.98 1.05
Multilevel 0.35 1.44 1.03 1.03 0.75 1.16 1.31 1.28 1.06 1.31 0.94 1.05 0.97 2.19 1.56 1.76 0.98 1.05
aGA gestational age
bBW birthweight
cSES socio-economic status
dNEC Necrotizing enterocolitis
esIVH intra−/periventricular hemorrhage grade 3–4
fBPD bronchopulmonary dysplasia
gsROP retinopathy of prematurity grade 3 and above
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was, at best, modest [36]. The same researchers main-
tain that even if perfect risk-adjustment was possible,
random error will result in some hospitals being mis-
classified [37]. The main rationale behind their claims
is that the often used AUC is a measure of discrimin-
ation: the degree to which the model can discriminate
between those patients with the outcome of interest
and those without the outcome of interest. As a con-
sequence it will be higher in a setting in which there
is greater heterogeneity in risk [36]. Thus, models
with low risk heterogeneity will be read as having low
predictive validity regardless of their ability to adjust
for risk.
Nevertheless, most published approaches to risk
adjustment still rely exclusively on factors known for
their high predictive validity such as severity of illness
scores like SNAP or CRIB in neonatology [11]. These
examples reflect NICU practices that were common at
the time of their development (1993), require up to 28
physiological data characteristics from up to the first
24 h of the new-born’s lives, a period during which they
are in the care of the clinics under observation for qual-
ity of performance, and require blood whereas differ-
ences in the timing of blood taking may affect risk
adjustment [8]. Another hindering issue is the difficulty
to achieve data completeness for all infants.
The SwissNeoNet selection of risk adjusters is there-
fore geared towards predictive validity, availability, and
measurability and is the result of a consensus process
among network members, by agreeing which factors the
clinics should not be held responsible for in quality
improvement and which factors should not be corrected
for as they are under the control of the clinics. For the
latter reason, we did not include caesarean section or
antenatal steroids because we did not want to attribute a
higher risk to clinics with lower rates in either of them.
Particularly in the case of antenatal steroids, the units
would have lost an opportunity to isolate a potential for
improvement. Because the effect of risk adjustment is
limited, members of the SwissNeoNet compare their
outcomes in standardized mortality / morbidity ratio
charts for stratified collectives and over pooled years.
Stratifying can involve limiting the evaluation to a
specific patient group such as from overall mortality to
in-hospital-mortality, or separate analysis for infants
born in different GA or birthweight groups. The
crude observed-expected ratio (together with its 95%
confidence interval) is displayed alongside its risk ad-
justed correspondent (Fig. 1). We also add the AUC
value and link to documentation for the interpretation
of the diagrams.
The strengths of our study lie in the quality and
completeness of our population based data, in the data
being covered for all live-born infants until death or
primary discharge home, and in separating the data into
training and validation sets. Switzerland provides wide
regional diversity expressed by 26 cantons with 26 health
care authorities, 4 languages, and 40% inhabitants with
migration background. This diversity is also reflected in
the up to 40% risk heterogeneity documented for mor-
tality. The high proportion of missing SES data required
imputation in a setting where data was not missing at
random. Thus, we cannot be certain that excluding SES
from mortality risk adjustment is correct. For the other
outcome models, SES was missing at random.
Almost 20 years ago, Iezzoni maintained that answer-
ing the question on how to isolate quality-of-care differ-
ences requires expensive, time-consuming, logistically
difficult, and methodologically complicated research and
that only a handful of studies had addressed this ques-
tion, most with equivocal results [34]. Risk adjustment
for quality improvement spans all medical disciplines
from alternative medicine to surgery and is performed
by researchers, administrators, government agencies and
health insurances. Yet we have not found a published
solution on how to effectively isolate quality-of-care dif-
ferences since Iezzoni’s comment other than approaches
that entailed visiting the participating clinics and asses-
sing the attributional validity of their risk adjustment
model on site, such as the DAVROS group [13]. But
besides having its own bias issues, this approach, requir-
ing independent experts, is personnel and time intensive.
We could not afford copying it for one outcome let
alone seven. It is therefore not so surprising that most of
the literature on risk adjustment relies on predictive
validity alone and measures neither change in attribu-
tional validity nor attributional validity itself. It would
no less be important to know if quality improvement
collaboratives with larger populations and/or differences
in case-mix risk show a larger effect of risk adjustment
and more effectively isolate quality differences.
Conclusions
To summarize, all three approaches to risk adjustment
revealed comparable results with high predictive validity
for mortality and several major morbidities. The indirect
standardization approach was surprisingly similar to the
other approaches.
In general, however, we conclude that risk adjustment
has a limited effect when comparing the outcome of
clinics with the same degree of specialization. We there-
fore propose that clinic outcomes be compared both in
risk-adjusted and un-adjusted form. The predictive validity
of the risk-adjustment should be quantified and reported.
To correct for confounding, stratification into risk groups
(such as gestational age or sex) could be used as an alter-
native to risk-adjustment. Rather than relying on the
purely methodological approach of risk-adjustment alone,
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as done ubiquitously by organizations delivering risk-
adjusted annual reports, our experience shows that
building small groups of clinic representatives and com-
bining their expertise with methodologically transparent
presentation of epidemiological data is very helpful in
isolating relevant quality improvement potential.
Additional file
Additional file 1: Table S1. Description: Comparison between expected
events when calculated by logistic regression using GA alone to approximate
indirect standardization stratified by gestational age weeks for 2013–2014.
(DOCX 17 kb)
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